An aerosol-based drug treatment could drastically reduce the number of new coronavirus patients dying from the disease or requiring intensive care, according to preliminary results released Monday by a British biotech firm. In a randomized trial of 100 patients admitted to hospital with Covid-19, those who received an inhaled formula of the protein interferon beta […]
